Skip to main content
. 2018 Jan 22;13:10. doi: 10.1186/s13014-018-0952-y

Table 2.

Mean liver dose (MLD) and proportion of circulating lymphocytes receiving ≥0.5Gy (CL0.5) by intrahepatic locations as a mean for all treatment modalities and beam energies

2. Dependence on tumor location
Tumor location MLD CL0.5
Apical 3.1 Gy 18.8%
Basal 3.4 Gy 19.0%
Central 5.3 Gy 31.3%